These findings were consistent with the significant positive correlations between DNMT1 and Ki-67 protein levels in both stage III (r = 0.58, p = 0.015, Figure 6F) and stage IV (r = 0.29, p = 0.0002, Figure 6G) melanoma patients. The gene discussed is DNMT1; the disease is melanoma.